JPS58109417A - セロトニンの代謝欠之を補正するための新規な薬剤 - Google Patents

セロトニンの代謝欠之を補正するための新規な薬剤

Info

Publication number
JPS58109417A
JPS58109417A JP57160728A JP16072882A JPS58109417A JP S58109417 A JPS58109417 A JP S58109417A JP 57160728 A JP57160728 A JP 57160728A JP 16072882 A JP16072882 A JP 16072882A JP S58109417 A JPS58109417 A JP S58109417A
Authority
JP
Japan
Prior art keywords
htp
inosine
composition according
complex
purine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57160728A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6254403B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
クロ−ド・ラルイエル
マルセル・ルパン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panmedica SA
Original Assignee
Panmedica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panmedica SA filed Critical Panmedica SA
Publication of JPS58109417A publication Critical patent/JPS58109417A/ja
Publication of JPS6254403B2 publication Critical patent/JPS6254403B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Indole Compounds (AREA)
JP57160728A 1981-09-16 1982-09-14 セロトニンの代謝欠之を補正するための新規な薬剤 Granted JPS58109417A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8117492 1981-09-16
FR8117492A FR2512672A1 (fr) 1981-09-16 1981-09-16 Nouvelles compositions a base de 5-hydroxytryptophane, leur procede de preparation et medicaments les contenant
FR8213980 1982-08-11

Publications (2)

Publication Number Publication Date
JPS58109417A true JPS58109417A (ja) 1983-06-29
JPS6254403B2 JPS6254403B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-11-14

Family

ID=9262193

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57160728A Granted JPS58109417A (ja) 1981-09-16 1982-09-14 セロトニンの代謝欠之を補正するための新規な薬剤

Country Status (3)

Country Link
JP (1) JPS58109417A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2512672A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA826752B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994001114A1 (en) * 1992-07-08 1994-01-20 Kyowa Hakko Kogyo Co., Ltd. Antidepressant

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3532684A (en) * 1966-06-18 1970-10-06 Ajinomoto Kk Molecular compounds of inosine and tryptophan
FR2081539A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1970-02-25 1971-12-03 Made Labor Sa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1535778A (en) * 1976-12-06 1978-12-13 Mac Sweeney D Compounds useful in treatment of unipolar depression
DE2841170A1 (de) * 1978-09-21 1980-04-03 Pharmazeutische Praeparate Apo Hypnotikum

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3532684A (en) * 1966-06-18 1970-10-06 Ajinomoto Kk Molecular compounds of inosine and tryptophan
FR2081539A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1970-02-25 1971-12-03 Made Labor Sa

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994001114A1 (en) * 1992-07-08 1994-01-20 Kyowa Hakko Kogyo Co., Ltd. Antidepressant

Also Published As

Publication number Publication date
FR2512672A1 (fr) 1983-03-18
ZA826752B (en) 1983-07-27
FR2512672B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1984-02-24
JPS6254403B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-11-14

Similar Documents

Publication Publication Date Title
JP7473642B2 (ja) Ｂｔｋ阻害剤としてのピロロピリミジン系化合物およびその使用
RU2118317C1 (ru) (-)-[[4-(1,4,5,6-тетрагидро-4-метил-6-оксо-3-пиридазинил)фенил]гидразоно]пропандинитрил и его фармацевтически приемлемые соли, фармацевтическая композиция на его основе, способ получения промежуточного соединения и способ получения целевого соединения
WO2018233633A1 (zh) Ssao 抑制剂
CA2832483A1 (en) Methods and compositions for treating neurodegenerative diseases
JPH11501925A (ja) 置換Ｎ−アリールメチルおよびヘテロシクリルメチル−１Ｈ−ピラゾロ〔３，４−ｂ〕キノリン−４−アミン並びにそれらを含有する組成物
US20140066434A1 (en) Methods and Compositions for Treating Parkinson's Disease
ES2277444T3 (es) Arilalcanoilpiridazinas.
TW200823190A (en) 2-aminocarbonyl-pyridine derivatives
CN107382902A (zh) 噻唑类衍生物及其应用
CN105451741A (zh) 布鲁顿酪氨酸激酶的抑制剂
US4472387A (en) Pharmaceutical compositions capable of increasing cerebral serotonin concentration
CN106632245A (zh) 氮取代基苯基吡唑类黄嘌呤氧化还原酶抑制剂及制备与应用
JPS58109417A (ja) セロトニンの代謝欠之を補正するための新規な薬剤
RU1777601C (ru) Способ получени производных тиоурацила или их фармацевтически приемлемых кислотно-аддитивных солей
JPS58188879A (ja) シプロヘプタジン−３−カルボン酸及び構造的に関連した化合物のエステル
JP2807633B2 (ja) Ｎ−（ピリジニル）−ｉｈ−インドール−１−アミンを含有する強迫疾患治療剤
JP2019522651A (ja) タンパク質キナーゼ阻害剤としての置換されているピロロ［２，３−ｄ］ピリダジン−４−オン及びピラゾロ［３，４−ｄ］ピリダジン−４−オン
ES2939506T3 (es) Derivado de tiadiazol y usos del mismo como inhibidor de GLS1 para el tratamiento de cáncer
JPH10507446A (ja) ビス−２−アミノピリジン類、その製造方法及び寄生虫感染を制御するためのその用途
JPH07503023A (ja) チアゾリルピリジン誘導体およびその胃酸分泌阻害剤としての用途
KR20180020119A (ko) 새로운 5형포스포디에스테라아제 억제제 및 그 용도
CN115894376B (zh) 一种芳香族酰胺类化合物、药物组合物及其用途
EP2234998A2 (en) Specific inhibitors of pteridine reductase with antiparasitic action
WO2022234069A1 (en) Novel 2-aminooxazoles derivatives and use thereof for treating infectious diseases
JPS60132967A (ja) ピラジノン誘導体